Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA)

Vaccine

Volumn 22, Issue 9-10, 2004, Pages 1199-1205

  Chakrabarti, Rabindranath ^a   Chang, Yigang ^b   Song, Keli ^c   Prud'homme, Gerald J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adjuvant; DNA vaccination; Interleukin 12; Interleukin 4; Membrane bound cytokines

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DNA VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENETIC CODE; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SOLUBILITY; TREATMENT OUTCOME; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, LEWIS LUNG; CERCOPITHECUS AETHIOPS; COS CELLS; IMMUNIZATION; INTERLEUKIN-12; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PLASMIDS; SPLEEN; VACCINES, DNA;

EID: 1542360820     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.09.023     Document Type: Article

References (29)

1. Kowalczyk D.W., Ertl H.C.J. Immune responses to DNA vaccines. Cell Mol Life Sci. 55:1999;751-770.
2. Cohen A.D., Boyer J.D., Paul D.B. Modulating the immune response to genetic immunization. FASEB J. 12:1998;1611-1626.
3. Jondal M.C., Shirmbeck R., Reimann J. MHC class I-restricted CTL response to exogenous antigens. Immunity. 5:1996;295-302.
4. Raychaudhuri S., Morrow W.J. Can soluble antigen induce CD8+ cytotoxic T cell response? A paradox revisited. Immunol Today. 14:1993;344-348.
5. Conry R.M., LoBuglio A.F., Loechel F., Moore S.E., Amuerel L.A., Barlow D.L.et al. A carcinoembryonic antigen polynucleotide vaccine has in vivo anti-tumor activity. Gene Therapy. 2:1995;59-65.
6. Conry R.M., LoBuglio A.F., Curiel D.T. Polynucleotide-mediated immunization therapy of cancer. Semin Oncol. 23:1996;135-147.
7. Conry R.M. Phase Ia trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer. Hum Gene Ther. 7:1996;755-772.
8. Song K., Chang Y., Prud'homme G.J. Regulation of T-helper-1 versus T-helper-2 activity and enhancement tumor immunity by combined DNA-based vaccination and non-viral cytokine gene transfer. Gene Therapy. 7:2000;481-492.
9. Song K., Chang Y., Prud'homme G.J. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune gene knockout mice. Gene Therapy. 7:2000;1527-1535.
10. Amici A., Venanzi F.M., Concetti A. Genetic immunization of against neu/erB2 transgenic breast cancer. Cancer Immunol Immunother. 47:1998;183-190.
11. Chen Y., Hu D., Eling D.J., Robbins J., Kips T.J. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res. 58:1998;1965-1971.
12. Weber L.W., Brown W.B., Wolchok J.D., Srinivasan R., Oin J., Moroi Y.et al. Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest. 102:1998;1256-1264.
13. Irvine K.R., Rao R.B., Rosenberg S.A., Restito N.P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol. 156:1996;238-245.
14. McLaughlin J.P., Scholm J., Kantor J.A., Greimer J.W. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination of Interleukin-2. Cancer Res. 56:1996;2361-2367.
15. Ishii K.J., Weiss W.R., Ichimo M., Verthelyi D., Klinmann D.M. Activity and safety o DNA plasmids encoding IL-4 and IFNgamma. Gene Therapy. 6:1999;237-244.
16. Sin J.I., Kim J.J., Boyer J.D., Ciccarelli R.B., Higgins T.J., Weiner D.B. In vivo modulation of vaccine-induced immune response toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. J Virol. 73:1999;501-509.
17. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y.et al. Modulation of amplitude and direction of in vivo immune response by co-administration of cytokine gene expression cassettes with DNA immunogens. Euro J Immunol. 28:1998;1089-1103.
18. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T.et al. Development of TH1 and TH2 populations and the nature of immune response to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol. 160:1998;1320-1329.
19. Tsuji T., Hamajima k., Fukushima J., Xin K.D., Ishii N., Aoki I.et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encode HIV-1 antigen with plasmid expressing IL-12. J Immunol. 158:1997;4008-4013.
20. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B.et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 158:1997;816-826.
21. Michael G., Gesien A., Tokushige K., Wands J.R. Enhancement of cellular and humoral immune response to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol. 158:1997;1231-1237.
22. Ogarra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
23. Howarth C, Maini RN, Feldmann M. Cytokine and anticytokine therapy. In: Thompson A, editor. The cytokine handbook. San Diego: Academic Press: 1998. p. 777-801.
24. Prud'homme G.J., Chang Y. Prevention of autoimmune diabetes by intramuscular gene therapy with a non-viral vector encoding interferon-gamma receptor/IgG1 fusion protein. Gene Therapy. 6:1999;771-777.
25. Croze F., Prud'homme G.J. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes. J. Gen. Med. 5:2003;425-437.
26. Yei S., Bartholomew R.M., Pezzoli P., Gutierrez A., Gouveia E., Bassett D.et al. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine. Gene Therapy. 9:2002;1302-1311.
27. Kim Y.S., Sonn C.H., Paik S.-G., Bothwell A.L.M. Tumor cells expressing membrane-bound IL-4 induce antitumor immunity. Gene Therapy. 7:2000;837-843.
28. Hochrein H., O'Keeffe M., Luft T., Vandenabeele S., Grumount R.J., Maraskovsky E. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med. 192:2000;823-833.
29. D'Andrea A., Ma X., Aste-Ameza M., Paganium C., Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by humanperipheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med. 181:1995;537-546.